Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 799

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Extracorporeal Life Support in Infarct-Related Cardiogenic Shock

Open access
Thiele, Holger, Zeymer, Uwe, Akin, Ibrahim, Behnes, Michael, Rassaf, Tienush, Mahabadi, Amir Abbas, Lehmann, Ralf, Eitel, Ingo, Graf, Tobias, Seidler, Tim, Schuster, Andreas, Skurk, Carsten, Duerschmied, Daniel, Clemmensen, Peter, Hennersdorf, Marcus, Fichtlscherer, Stephan, Voigt, Ingo, Seyfarth, Melchior, John, Stefan, Ewen, Sebastian, Linke, Axel, Tigges, Eike, Nordbeck, Peter, Bruch, Leonhard, Jung, Christian, Franz, Jutta, Lauten, Philipp, Goslar, Tomaz, Feistritzer, Hans-Josef, Pöss, Janine, Kirchhof, Eva, Ouarrak, Taoufik, Schneider, Steffen, Desch, Steffen, Freund, Anne·2023·New England Journal of Medicine

Abstract

BACKGROUND: Extracorporeal life support (ECLS) is increasingly used in the treatment of infarct-related cardiogenic shock despite a lack of evidence regarding its effect on mortality. METHODS: In this multicenter trial, patients with acute myocardial infarction complicated by cardiogenic shock for whom early revascularization was planned were randomly assigned to receive early ECLS plus usual medical treatment (ECLS group) or usual medical treatment alone (control group). The primary outcome was death from any cause at 30 days. Safety outcomes included bleeding, stroke, and peripheral vascular complications warranting interventional or surgical therapy. RESULTS: A total of 420 patients underwent randomization, and 417 patients were included in final analyses. At 30 days, death from any cause had occurred in 100 of 209 patients (47.8%) in the ECLS group and in 102 of 208 patients (49.0%) in the control group (relative risk, 0.98; 95% confidence interval [CI], 0.80 to 1.19; P = 0.81). The median duration of mechanical ventilation was 7 days (interquartile range, 4 to 12) in the ECLS group and 5 days (interquartile range, 3 to 9) in the control group (median difference, 1 day; 95% CI, 0 to 2). The safety outcome consisting of moderate or severe bleeding occurred in 23.4% of the patients in the ECLS group and in 9.6% of those in the control group (relative risk, 2.44; 95% CI, 1.50 to 3.95); peripheral vascular complications warranting intervention occurred in 11.0% and 3.8%, respectively (relative risk, 2.86; 95% CI, 1.31 to 6.25). CONCLUSIONS: In patients with acute myocardial infarction complicated by cardiogenic shock with planned early revascularization, the risk of death from any cause at the 30-day follow-up was not lower among the patients who received ECLS therapy than among those who received medical therapy alone. (Funded by the Else Kröner Fresenius Foundation and others; ECLS-SHOCK ClinicalTrials.gov number, NCT03637205.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa2307227

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 799

Metadata

Authors
Thiele, H., Zeymer, U., Akin, I., Behnes, M., Rassaf, T., Mahabadi, A. A., Lehmann, R., Eitel, I., Graf, T., Seidler, T., Schuster, A., Skurk, C., Duerschmied, D., Clemmensen, P., Hennersdorf, M., Fichtlscherer, S., Voigt, I., Seyfarth, M., John, S., Ewen, S., Linke, A., Tigges, E., Nordbeck, P., Bruch, L., Jung, C., Franz, J., Lauten, P., Goslar, T., Feistritzer, H.-J., Pöss, J., Kirchhof, E., Ouarrak, T., Schneider, S., Desch, S., & Freund, A.
Venue
New England Journal of Medicine
Published
2023-10-05
Volume
389
Issue
14
Pages
1286-1297
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4386208393
Cited by
799
References
21
FWCI
58.39
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. https://app.cochat.ai/papers/10.1056/nejmoa2307227
The paper
Thiele, H., Zeymer, U., Akin, I., Behnes, M., Rassaf, T., Mahabadi, A. A., Lehmann, R., Eitel, I., Graf, T., Seidler, T., Schuster, A., Skurk, C., Duerschmied, D., Clemmensen, P., Hennersdorf, M., Fichtlscherer, S., Voigt, I., Seyfarth, M., John, S., . . . Freund, A. (2023). Extracorporeal Life Support in Infarct-Related Cardiogenic Shock. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2307227

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.